Recent Publications

Refereed Publications

Journals (Asterix * indicates my trainee as first author)

1. Gong B, Shojania K, Khosa F, Nicolaou S. Referral patterns for Dual-Energy Computed Tomography in diagnosis and management of gout: Ten-year experience at a Canadian institution. Can Ass Rad J;2018(69)430-6
2. *Huang K, Shojania K, Chapman K, Amiri N, Dehghan N, Mezei M. Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review. Sem Arthritis Rheum (2018) in press
3. *Howren A, Cox SM, Shojania K, Rai SK, Choi HK, De Vera MA. How patients with gout become engaged in disease management: a constructivist grounded theory study. Arthritis Research and Therapy 2018:1-8
4. *Rai SK, Choi HK, Choi SHJ, Townsend AF, Shojania K, De Vera MA. Key barriers to gout care: A systematic review and thematic synthesis of qualitative studies. Rheumatology 2018; (57):1282-92
5. Manku S, Wong W, Luo Z, Seidman M, Alaburubalnabi Z, Rey K, Wnns W, Avina-Zubieta JA, Shojania K, Choy JC. IL-6 Expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis. Cardiovasc Path 2017: online pub.
6. Estrada A, Tsao NW, Howren A, Esdaile JM, Shojania K, De Vera MA. Utility of electronic medical records in community rheumatology practice for assessing quality of care indicators for gout. J Clin Rheum 2017:e1-e5
7. Winstone TA, Levy RD, Shojania K, Murphy D, Churg A, Ryerson C. Organizing pneumonia in an adult with chronic recurrent non-infectious osteomyelitis: A care report and literature review. Chest 2017 (2):e21-e24
8. Bouquet J, Gardy JL, Brown S, Pfeil J, Milleer RR, Morshed M, Avina-Zubieta A, Shojania K, McCabe M, Parker S, Uyaguary M, Federman S, Tang P, Steiner T, Otterstater M, Holt R, Moore R, Chiu CY, Patrick D. RNA-Seq analysis of gene expression, viral pathogen, and B-cell/T-cell receptor signatures in complex chronic disease. Clinical Infectious Diseases 2017;476-481
9. Rai S, Avina-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, Choi HK. The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. Sem Arthritis Rheum 2016;
10. Bansback N, Shojania K, Lacaille D. Improving patient-centred care for rheumatoid arthritis. CMAJ 2016: 1-2
11. *Samycia M, McCourt C, Shojania K, Au S. Experiences from a combined dermatology and rheumatology clinic: A retrospective review. J Cut Med Surg 2016;(5):486-9
12. Cividino A, Bakowsky V, Barr S, Bessette L, Hazel E, Khalidi N, Pope J, Robinson D, Shojania K, Yacyshyn E, Lohfeld L, Crawshaw D. How to attract trainees, a pan-Canadian perspective: Phase 1 of the “Training the rheumatologists of tomorrow” project. J Rheum 2016;43(4):788-98
13. Braschi E, Shojania K, Allan GM. Anti-CCP: A truly helpful rheumatoid arthritis test? Can Fam Phys 2016;62(3)234
14. *Wong IT, Shojania K, Dutz J, Tsao NW. Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis. Expert review of pharmacoeconomics & outcomes research. 2015 Dec 17
15. Fitzcharles, M-A, Ste-Marie PA, Hauser W, Clauw DJ, Jamal S, Karsh J, Landry T, KeClercq, McDougall JJ, Shir Y, Shojania K, Walsh Z. Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials. Arthritis Care and Research. Accepted Online Nov 2015
16. McGeoch L, Twilt M, Famorca L, Bakowsky V, Barra L, Benseler SM, Cabral DA, Carette S, Cox GP, Dhindsa N, Dipchand CS, Fifi-Mah A, Goulet M, Kalidi N, Khraishi MM, Liang L, Milman N, Pineau CA, Reich HN, Samadi N, Shojania K, Taylor-Gjevre, Towheed TE, Trudeau J, Walsh M, Yacyshyn E, Pagnoux for the Canadian Vasculitis Research Network. CanVasc Recommendations for the management of Antineutrophil Cytoplasm Antibody-associated Vasculitides. J Rheum 2015;42(12):1-24
17. Patrick DM, Miller RR, Gardy JL, Parker SM, Morshed M, Steiner TS, Singer J, Shojania K, Tang P. Clinical Infectious Diseases 2015;61(7):1084-91
18. Harrison M, Marra C, Shojania K, Bansback N. Societal preference for rheumatoid arthritis treatments: Evidence from a discrete choice experiment. Rheumatology 2015:54(10): 1816-25
19. Famorca L, Twilt M, Barra L, Bakowsky V, Benselere S, Cabral D, Carette S, Dhindsa N, Fifi-Mah A, Goulet M, Khalidi N, Khraishi M, McGeoch L, Milman N, Pineau C, Shojania K, Taylor-Gjevre R, Towheed T, Trudeau J, Yacyshyn E, Liang P, Pagnoux C. Development of Canadian recommendations for the management of ANCA-associated vasculitides: Results of the national needs assessment questionnaire. Open Rheumatology 2015;9:16-20.
20. Fitzcharles MA, Ste-Marie PA, Clauw DJ, Jamal S, Karsh J, LeClercq S, McDougall JJ, Shir Y, Shojania K, Walsh Z. Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints. BMC Musculoskel Disord 2014;15:258
21. *Chen Y, Sreenivasan GM, Shojania K, Yoshida EM. Cryofibrinogenemia After a Liver Transplant: First Reported Case Posttransplant and a Case-Based Review of the NontransplantLiterature. Exp Clin Trans 2015;13(3):290-4
22. *Kirchhof MG, Shojania K, Hull MW, Crawford RI, Au S. Trichodysplasia Spinulosa: Rare Presentation of Polyomavirus Infection in Immunocompromised Patients. J Cut Med Surg 2014;18:1-6
23. *Man A, Shojania K, Phoon C, Pal J, de Badyn MH, Pi D, Lacaille D. An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol. 2013 May;32(5):601-8.
24. Tsao NW, Shojania K, Marra C. Cost–effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Ex Rev Pharm Out Res 2014, 14(1):9-18
25. Tsao NW, Bansback NJ, Shojania K, Marra CA. The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2012 Oct;26(5):659-76
26. Russell, AS, Ahluwalla V, Jamal S, Offer RC, Olszynski WP, Shojania K, Haraoui B. Subsequent entry biologics/biosimilars: a viewpoint from Canada Clin Rheumatol 2012;(9):1289-92
27. Pi D, Hudoba de Badyn M, Nimmo M, White R, Pal J, Wong P, Phoon C, O’Connor D, Pi S, Shojania K. Application of linear discriminant analysis in performance: Evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases. Am J Clin Pathol 2012;138;596-603
28. Choi HK, Burns LC, Shojania K, Koenig N, Reid G, Abufayyah M, Law G, Kydd AS, Ouellette H, Nicolaou S Dual Energy CT in gout: a prospective validation study. Ann Rheum Dis 2012 Sep;71(9):1466-71
29. Marra CA, Bansback N, Anis AH, Shojania K. Introduction to economic modeling for clinical rheumatologists: Application to biologics in rheumatoid arthritis. Clin Rheumatol 2011;30 Suppl 1:S9-18
30. Lehman AJ, Pratt DD, DeLongis A, Collins JB, Shojania K, Koehler B, Offer R, Esdaile JM. Do spouses know how much fatigue, pain and physical limitations their partners with rheumatoid arthritis experience? Implications for social support. Arthritis Care Res 2011;63(1):120-7.
31. Katchamart W, Bourre-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, Leclerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C. Canadian 3e Initiative Consensus Group. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis. J Rheumatol 2010;37(7):1422-30.
32. Choi HK. Al-Arfaj AM. Eftekhari A. Munk PL. Shojania K. Reid G. Nicolaou S. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009;68(10):1609-12.
33. *Hemmati I, Ensworth S, Shojania K. Coarctation of the Aorta in an Infant Exposed to Etanercept in Utero. J Rheumatol 2009;36(12):2848.
34. Shojania K, Ratzlaff M. Group visits for rheumatoid arthritis. A pilot study. Clin Rheumatol. 2009;29(6):625.
35. Cibere J, Thorne A, Bellamy N, Greidanus N, Chalmers A, Mahomed N, Shojania K, Kopec J, Esdaile JM. Reliability of the hip examination in osteoarthritis: Effect of standardization. Arthritis Rheum 2008;59:373-81.
36. Maksymowych, WP, Rahman, P, Shojania, K, Olszynski, WP, Thomson, GTD, Ballal, S, Wong, RL, Inman, RD. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J Rheumatol 2008;35:2030;7.
37. Iverson GL, Le Page J, Koehler BK, Shojania K, Badii M. Test of memory malingering (TOMM) scores are not affected by chronic pain or depression in patients with fibromyalgia. Clinical Neuropsychologist 2007;21:532-46.
38. de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP. Psoriasis and pustular dermatitis triggered by TNF alpha inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007;143:223-31.
39. *Kherani RB, Shojania K. Septic arthritis in patients with pre-existing inflammatory arthritis. CMAJ 176:1605-8. 2007
40. Maksymowych, WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L,Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R. The Canadian Rheumatology Association/Spondylitis Research Consortium of Canada treatmen14recommendations for the management of Spondyloarthritis: A national multidisciplary stakeholder project. J Rheumatol 2007;34:2273-84.
41. *Reynolds J, Shojania K, Marra CA. Abatacept: A novel treatment for moderate to severe rheumatoid arthritis. Pharmacotherapy 2007;27(12):1693-701.
42. Dunne J. Dutz J. Shojania K. Ng B. van Eeden S. Treatment of severe Raynaud’s phenomenon with bosentan in a patient with systemic sclerosis. Rheumatology. 2006;45:911-2.
43. Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis: Focus on Tumour Necrosis Factor-alpha Antagonists. Drugs 2005;65:473-496.
44. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. A comparison of generic, indirect utility measures (the HU12, HU13, SF-6D, and the EQ 5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005;60:1571-82.
45. Cibere J, Bellamy N, Thorne A, McGorm K, Esdaile JM, Chalmers A, Huang S, Peloso P, Shojania K, Singer J, Wong H, Kopec J. Reliability of the knee examination in osteoarthritis: Effect of standardization. Arthritis Rheum 2004;50:458-68.
46. *Nahar I, Shojania K, Marra CA, Alamgir AH, Anis AH. Infliximab: A qualitative review of its role in the treatment of rheumatoid arthritis and Crohn’s disease. Annals Pharmacother 2003;37: 1256-65.
47. Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol 2003;30:493-7.
48. Shojania K. Rheumatology: 2. What laboratory tests are needed? CMAJ 2000;162:1157-63.
49. Shojania K, Koehler BE, Elliot T. Hypoglycemia induced by hydroxychloroquine in a Type II diabetic treated for polyarthritis. J Rheumatol 1999;26:195-6.
50. Shojania K, Chalmers A, Rangno K. Cyclosporin-A in the treatment of adult Still’s disease. J Rheumatol 1995; 22:1391-92.

Non-Refereed Publications

a) Journals

1. Shojania K, Amiri N. Part 1: Treating Gout – Practice tips and clinical pearls. This Changed My Practice: http://thischangedmypractice.com/part-2-treating-gout-practice-tips/
2. Shojania K, Amiri N. Part 2: Diagnosing Gout in Primary Care Settings: Do we have to tap? This Changed My Practice: http://thischangedmypractice.com/part-1-diagnosing-gout/
3. Shojania K, Amiri N. Five Clinical Points on Rheumatoid Arthritis in Family Practice. This Changed My Practice: http://thischangedmypractice.com/rheumatoid-arthritis/ January 2014
4. Shojania K, Amiri N. Effects of glucocorticoids on cardiovascular risks in patients with rheumatoid arthritis. This Changed My Practice: http://thischangedmypractice.com/ September 23, 2013
5. Shojania K. Clinical Abstracts. Rheumatology Cases and Clinical Review. Spring 2007.
6. Shojania K. Editorial. Rheumatology Cases and Clinical Review. Fall 2007.
7. Shojania K, Wade JP. The Investigation and Management of Gout, J Can Rheum Assoc 1998; 8(1):10-14.
8. Koehler BK, Adler RN, Fishman M, Gray JR, Huang S, Shojania K. British Columbia 1997 Consensus Meeting on the utilization of nonsteroidal anti-inflammatory agent, BCMJ 1998; 40(6):252-6.
9. Shojania K, Wade JP. Managing Your Gouty Patient. Canadian Journal of Diagnosis 1997; 14(10):113-122.
10. Wade JP, Shojania K. Osteoporosis: Prevention and treatment update. Canadian Journal of Continuing Medical Education 1994; 6:49-57.

b) Abstracts

1. *Huang K, Mezei M, Shojania K, Chapman K, Amiri N, Dehghan N, Dehghan N. Inflammatory myositis associated with myasthenia gravis with or without thymic pathology: Case series and literature review. 2018 CRA meeting abtract 206
2. *Huang K, Shojania K, Yeung J, Avina-Zubieta A. MDA5 positive clinical amyopathic dermatomyositis (CADM): A single centre case series of 10 patients. 2018 CRA meeting abstract 205
3. Kazem M, Maberley D, Choi HK, Tavakoli H, Shojania K, Esdaile J, Avina-Zubieta A. Gaps in screening for retinal toxicity in patients with SLE and RA exposed to antimalarials: A population-based study. 2018 CRA meeting Abstract 55
4. Khamis N, Khosravi T, Shojania K, Nimmo M, Avina-Zubieta A, Dehghan N. Evaluation of the indications for ANCA testing and its diagnostic utility 2018 CRA meeting Abstract 28
5. *Daghistani Y, To F, Doyle P, Ko HH, Krajden M, Kur J, Ramji A, Shojania K, Tam E, Wade J, Yoshida E, Reid G, Erb S, Carruthers M. Hepatitis B reactivation in rheumatologic patients. CRA 2017 Abstract 1099
6. *Howren A, Tsao N, Shojania K, Kydd A, Friesen R, De Vera M. eHealth supported collaborative care for gout involving rheumatology, pharmacy and dietetics: Mid-term outcomes. J Rheum 2017 Abstract 204
7. Kherani R, Yao C, Collins D, Eva K, Jamal S, Koehler B, Novak-Lauscher H, Shojania K, Ho K. Remote Assessment via video evaluation (RAVVE): Video-based peer assessment to support rheumatology continuing professional development. J Rheum 2017 Abstract 202
8. Estrada A, Tsao N, Galo J, Shojania K, Esdaile J, De Vera M. Assessing gout quality indicators in electronic medical records: A feasibility study. J Rheum 2016 Abstract 34
9. *Bardi M, Shojania K, Kur J, Watterson J, Hiltz M, Manhas K, Roth J, Sayre E, Li L, Oliver C, Collins D. CRUS control: A retrospective analysis of a Canadian rheumatology ultrasound clinic: Preliminary results. J Rheum 2016 Abstract 143
10. Rai S, Avina-Zubieta A, McCormick N, De Vera M, Shojania K, Hughes G, Sayre E, Choi H. The rising prevalence and incidence of gout in British Columbia, Canada. J Rheum 2016 Abstract 221
11. Bansback N, Lacaille DV, Guh D, Shojania K, Anis A. Estimating cost savings attributable to increased use of triple therapy [abstract] J Rheumatol 2015;42.
12. Cividino A, Bakowsky V, Barr S, Bessette L, Khalidi N, Pineau C, Pope JE, Robinson D, Shojania K, Yacyshyn E, Lohfeld, Crawshaw, D. Training the rheumatologists of tomorrow. The Canadian experience Arthritis Rheumatol. 2015; 67 (suppl 10).
13. *Yurkovich M, Choi HK, Sayre EC, Shojania K, Avina-Zubieta A. Increased risk of deep vein thrombosis and pulmonary embolism in Sjogrens syndrome: A general population-based cohort study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10).
14. Bansback N, Lacaille DV, Guh D, Shojania K, Anis A. Economic implications for policies regarding triple therapy use in patients with rheumatoid arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10).
15. *Amiri N, Dehghan N, Sayre EC, Shojania K, Avina-Zubieta A. Increased risk of myocardial infarction and cerebrovascular accidents after diagnosis of granulomatosis with polyangiitis: A general population-based cohort study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10).
16. Rai SK, Avina-Zubieta JA, McCormick N, De Vera M, Shojania K, Sayre EC, Choi HK. Rising Incidence and Prevalence of Gout in the Canadian General Population [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10).
17. *Yurkovich M, Sayre EC, Shojania K, Avina-Zubieta A, The Risk of Myocardial Infarction and Cerebrovascular Accident in Patients with Sjogrens Syndrome: A General Population-Based Cohort Study. EULAR Paris OP0212
18. Cividino A, Barr S, Bakowsky V, Bessette L, Homik J, Khaladi N, Pineau C, Pope J, Robinson D, Shojania K, Yacyshyn E. Creating New Rheumatologists: The Canadian Experience. EULAR Paris 2014 SAT0576
19. *Hemmati I, Sayre E, Choi H, Shojania K, Avina-Zubieta A. The Risk of Myocardial Infarction in Systemic Sclerosis: A Population-Based Study. J Rheum 42(7): 1554
20. *Amiri N, Dehghan N, Sayre E, Shojania K, Avina-Zubieta A. Risk of Cardiovascular Events in Patients with Granulomatosis with Polyangiitis: A Population-Based Study. J Rheum 41(7):1547-8
21. *Dehghan N, Amiri N, Shojania K, Sayre E, Avina-Zubieta A. Venous Thromboembolic Events in Patients with Granulomatosis with Polyangiitis: A Population-Based Study. J Rheum 41(7):1345
22. *Renwick M, Esdaile J, Kur J, Shojania K. Evaluation of BC Rheumatologists’ Triage of Early Rheumatoid Arthritis. J Rheum 41(7):1540
23. *Yurkovich M, Choy H, Agha M, Hemmati I, Sayre E, Shojania K, Avina-Zubieta A. The Risk of Cerebrovascular Accidents in Systemic Sclerosis: A Population-Based Cohort Study. J Rheum 41(7):1539
24. *Marcotte G, Shojania K, Chalmers A. A Screening Failure. J Rheum 41(7):1530
    Carruthers E, Sayre E, Shojania K, Avina-Zubieta A, Risk of Venous Thromboembolism in Individuals with Dermatomyositis and Polymyositis. J Rheum 41(7):1526
25. Fitzcharles MA, Ste-Marie PA, Clauw DJ, Jamal S, Karsh J, LeClercq S, McDougall JJ, Shir Y, Shojania K, Walsh Z. Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints. J Rheum 41(7):1472
26. Agha M, Esdaile J, Yurkovich M, Sayre E, Shojania K, Lacaille D, Avina-Zubieta A. Risk of Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus: A Population-Based Study. J Rheum 41(7):1438
27. Avina-Zubieta JA, Hemmati I, Sayre E, Shojania K, Choi HK, The Risk Of Pulmonary Embolism and Deep Venous Thrombosis In Systemic Sclerosis: A Population-Based Cohort. Presented at the American College of Rheumatology Meeting San Diego CA October 2013 Abstract 1814
28. *Amiri N, Choi HK, Sayre E, Shojania K, Avina-Zubieta JA. Risk Of Myocardial Infarction In Patients With Giant Cell Arteritis: A Population-Based Study. American College of Rheumatology Meeting San Diego CA October 2013
29. *Hemmati I, Choi HK, Shojania K, Sayre E, Avina-Zubieta JA. The Risk Of Myocardial Infarction In Systemic Sclerosis: A Population-Based Cohort Study. Presented at the American College of Rheumatology Meeting San Diego CA October 2013 Abstract 763
30. Fitzcharles M-A, Ste-Marie, PA, Clauw DJ, Jamal, S, Karsh J, Leclercq S, McDougall J, Shir Y, Shojania K, Walsh Z.Rheumatologists Lack Confidence in Their Knowledge of Cannabinoid Molecules and Use in the Management of Rheumatic Disease Patients: Analysis of a Needs Assessment. Presented at the American College of Rheumatology Meeting San Diego CA October 2013 Abstract 122
31. *Lockhart S, Jamal S, Shojania K. Regular Physical Exercise Incorporated into a Rheumatology Fellowship Curriculum: A Qualitative Survey of Participants. Presented at the Canadian Rheumatology Association Meeting, Ottawa ON February 2013 Abstract 168
32. *Uh M, Nicolaou S, Shojania K, Choi H, Reid G. Correlation of Monosodium Urate Gouty Tophi with Colour Coded Dual Energy. Presented at the Canadian Rheumatology Association Meeting, Ottawa ON February 2013 Abstract 146
33. Feehan LM, Bruie HR, Li LC, Shojania K, Barnabe C, McKay HA High resolution peripheral quantitative CT detects marked differences in metacarpal head and shaft and ultra-ultra-distal radius bone, volumetric density and microstructure in early rheumatoid arthritis. Presented at the American College of Rheumatology Meeting Washington DC Nov 2012 Arthritis Rheum 2012;64(10):S435-6
34. *Dehghan N, Shojania K, Avina-Zubieta, JA. Mortality in ANCA-associated vasculitis. A meta-analysis of observational studies. Presented at the Canadian Rheumatology Associating National Meeting March 2012 Abstract #106
35. Pi D, Pal J, O’Connor D, Wong P, Pi S, Nimmo M, Hudoba de Badyn M, Shojania K. Comparative performance of autoantibody immunoassays in the screening and diagnosis of systemic autoimmune rheumatic disease (SARD) – experience of a tertiary hospital laboratory Presented at the Canadian Rheumatology Associating National Meeting March 2012 Abstract #47
36. Avina-Zubieta, Sayre EC, Bernatsky S, Lehman AJ, Shojania K, Esdaile J, Lacaille D. Adult prevalence of systemic autoimmune rheumatic diseases (SARDs) in British Columbia, Canada Presented at the American College of Rheumatology Meeting San Fransisco Nov 2011 Abstract #1845
37. *MacCallum CA, Wall-Burns L, Bhole V, De Vera M, Nicolaou S, Shojania K, Reid GD. Articular tophus burden by dual-energy computer tomography and health-related quality of life. J Rheum 2011;38(6)1147
38. *Hemmati I, Yoshida EM, Shojania K. Relapsing polychondritis associated with hepatitis C virus infection. J Rheum 2011;38(6)1174
39. *Leger M, Rahman MM, Aghajanian J, Wade K, Choi H, Shojania K. Risk of developing myocardial infarction among uveitis patients J Rheum 2011;38(6)1183-4
40. *Man AW, Shojania K, Phoon C, Pal J, Hudoba de Badyn M, Pi D, Lacaille D. An evaluation of autoantibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. J Rheum 2011;38(6)1183
41. *Hemmati I, Ensworth S, Shojania K. Coarctation of the Aorta in an Infant Exposed to Etanercept in Utero. J Rheumatol 2009;36(11):2580.
42. *Ghanem A, Nahar I, Ensworth S, Huang S, Blocka K, Shojania K, Koehler BE, Chalmers A, Esdaile JM, Lacaille D. Comparison of the clinical manifestations and disease severity of systemic lupus erythematosus (SLE) among vancouver residents of Asian and Caucasian origin. J Rheumatol 2009;36(11):2610.
43. *Man A, Kherani R, Shojania K. Clostridium Difficile – associated reactive arthritis. Presented at the CRA annual meeting. Quebec City, Quebec. Feb 2009. Abstract #193.
44. Kirschner Q, Hasek-Watt, Koehn C, Esdaile J, Shojania K. Is there research funding and media discrimination against arthritis? J Rheumatol 2008;35(6):1182-3.
45. Inman R, Shojania K, Keystone E, Haraoui B, Mitchell C, Maksymowych W. Canadian evaluation of low dose infliximab in ankylosing spondylitis (CANDLE). J Rheumatol 2008;35(6):1213-4.
46. Cibere, J, Thorne A, Bellamy N, Chalmers A, Greidanus N, Mahomed N, Trithart S, Combes V, Shojania K, Kopec J, Esdaile JM. Reliability and standardization of the hip examination in osteoarthritis. J Rheumatol 2006;33:398.
47. Garcia-De La Torre I, Combe B, Covucci A, Li T, Weinblatt M, Shojania K. Abatacept improves patient-reported outcomes in rheumatoid arthritis patients receiving background DMARDs: 1-year safety results of the ASSURE trial. J Rheumatol 2006;33:397.
48. Pineda C, Combe B, Covucci A, Li T, Becker J-L, Aranda R, Shojania K. Abatacept for the treatment of rheumatoid arthritis patients receiving background disease-modifying antirheumatic drugs (DMARDs): Safety and patient-reported outcomes from the ASSURE trial. J Rheumatol 2006;33:397.
49. Maksymowych WP, Olczynski W, Sampalis J, Shojania K. The Maastricht and Spondyloarthritis Research Consortium of Canada Enthesitis Scores (MASES and SPENT): A comparison of their reliability and responsiveness. J Rheumatol 2006;33:382.
50. Inman RD, Shojania K, Keystone E, Haraoui B, Leombuno JP, Maksymowych WP. Efficacy of lower dose infliximab in active ankylosing spondylitis – Interim results of a Canadian study. Arthritis Rheum 2006;54(Suppl):S471.
51. Lehman, AJ, Pratt D, DeLongis A, Collins J, Shojania K, Koehler B, Offer R, Esdaile JM. Do Spouses know how much fatigue and pain their partners with rheumatoid arthritis experience? Implications for social support. Arthritis Rheum 2006;54(9 Suppl):S303.
52. Shojania K. Increasing interest in rheumatology training: A website approach. J Rheumatol 2005:32:1402.
53. LePage J, Iverson G, Koehler B, Shojania K, Badii M. An analog study of exaggerated pain and disability in fibromyalgia. J Rheumatol 2004:31:44.
54. Bansback N, Regier D, Ara R, Brennan A, Shojania K, Esdaile J, Anis A, Marra C. Cost-effectiveness analyses of TNF antagonists in rheumatoid arthritis: A review. Arthritis Rheum 2004;50;S510.
55. Shojania K. Do you want to be a rheumatologist? A web portal for trainees to discover rheumatology. J Rheumatol 2003;30: 1876.
56. *Collins D, Shojania K, Giustino J. Rheumatoid lung nodules preceding articular disease by more than two decades: An unusual onset of rheumatoid arthritis. J Rheumatol 2003;30: 1876.
57. Cibere J, Bellamy N, Thorne A, McGorm K, Esdaile JM, Chalmers A, Huang S, Peloso P, Shojania K, Singer J, Wong H, Kopec J. Reliability of the knee examination in osteoarthritis: Effect of standardization. Osteoarthritis Cartil 2002; 10 (suppl):S62.
58. Marra CA, Woolcott J, Shojania K, Brazier JE, Esdaile JM, Anis AH. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46 (suppl 74):90.
59. Shojania K, Koehler BE, Elliot T. Hypoglycemia induced by hydroxychloroquine in a Type Idiabetic treated for polyarthritis. J Rheumatol 1997; 24:1492.
60. Shojania K, Chalmers A, Rangno K. Are there late consequences to cyclosporin A treatment of rheumatoid arthritis? Arthritis Rheum 1995; 38:186.

Books

1. *Sun M, Shojania K. Approach to interpretation of laboratory tests 2nd Ed. In: The Canadian Clinician’s Rheumatology Handbook. Edited by Albert L. Brush Education Inc.
2. Shojania K, Greidanus N, Esdaile J. Arthritis. In: Orthopedic Knowledge Update 8. Edited by Vaccaro AR. Rosemont IL, American Academy of Orthopaedic Surgeons, 2005:229-44.
3. Shojania K. Changing paradigms in the treatment of inflammatory disorders. In: Orbital Disease, Present Status and Future Challenges. Edited by Rootman, J. Taylor & Francis Group. 2005:15-23.
4. Shojania K. Approach to selection and interpretation of laboratory tests. In: Canadian Residents’ Rheumatology Handbook. Edited by Albert L. Trafford Publishing. 2005: 110-122.
5. Shojania K. Topics in adult rheumatology. In: Intravenous Immune Globulin Utilization Management Handbook, The Provincial Blood Coordination Office. 2002:64-7.
6. Dubord P, Shojania K, Chalmers A, Ho V. Rheumatoid arthritis In: Diseases of the Eye and Skin Diseases, edited by Mannis MJ, Mascai MS, Huntley AC. New York, Raven Press, 1995:191-8.
7. Shojania K. Wade JP. Treatment of hyperuricemia and gout. In: Conn’s Current Therapy, edited by R. Rakel, W.B. Saunders, 1995:539-42.